Last edition
News about Global Pharma
Gland Pharma Secures Approval for Angiotensin II Acetate Injection
Gland Pharma has received USFDA approval for its Angiotensin II Acetate Injection, securing 180-day exclusivity as the First-to-File generic of GIAPREZA for treating distributive shock.
Global Pharma | 04/06/2025 | By Manvi | 177
UK's MHRA Grants Approval to Aumolertinib for Treatment of Non-Small Cell Lung Cancer
The UK’s MHRA has approved aumolertinib (Aumseqa) for adults with advanced non-small cell lung cancer carrying EGFR mutations, offering a new targeted treatment option for metastatic cases.
Global Pharma | 04/06/2025 | By Manvi | 356
Perma and UE Systems Launch UltraTrak VARIO for Smart Industrial Lubrication
perma has joined forces with UE Systems to redefine industrial lubrication. Central to this strategic partnership is the launch of the UltraTrak VARIO, a new solution within the OnTrak Wireless ecosystem.
Global Pharma | 03/06/2025 | By Manvi | 327
Johnson & Johnson MedTech Launches KINCISE 2 Surgical Automation System
Johnson & Johnson MedTech announced the launch of the KINCISE 2™ Surgical Automated System, a next-generation automated power tool engineered to improve surgical efficiency, provide control and aims to reduce physical burden on surgeons compared to manual impaction across both primary and revision hip and revision knee replacement procedures.
Global Pharma | 03/06/2025 | By Manvi | 237
Sun Pharma has announced that its Phase 2 trials for SCD-044 in psoriasis and atopic dermatitis did not meet primary efficacy endpoints of 75 percent improvement in PASI (Psoriasis Area and Severity Index) score (PASI75) at Week 16, prompting discontinuation of further development.
Global Pharma | 03/06/2025 | By Manvi | 198
Biocon Secures Approval for Diabetes Drug Liraglutide in India
Biocon Ltd. has received approval in India for its Liraglutide drug substance and drug product, marking a key milestone in expanding access to GLP-1 therapy for Type 2 diabetes.
Global Pharma | 03/06/2025 | By Manvi | 252
ASP Isotopes and Isotopia Ink Deal to Secure Gd-160 Supply for Cancer Therapy
This partnership addresses longstanding supply challenges for Gd-160, enabling Isotopia to advance Tb-161-based therapies for prostate cancer, neuroendocrine tumors, and other malignancies.
Global Pharma | 02/06/2025 | By Manvi | 272
Zydus Secures Tentative Approval from USFDA for Rifaximin Tablets, 550 mg
Zydus Lifesciences has received tentative USFDA approval for Rifaximin Tablets, 550 mg, used to treat IBS-D in adults.
Global Pharma | 02/06/2025 | By Manvi | 213
Moderna Secures US FDA Approval for COVID-19 Vaccine mNEXSPIKE
Moderna has received FDA approval for mNEXSPIKE (mRNA-1283), its next-generation COVID-19 vaccine, for adults 65+ and at-risk individuals aged 12–64, ahead of the 2025–2026 respiratory virus season.
Global Pharma | 02/06/2025 | By Manvi | 220
Astellas Pharma has entered an exclusive licensing agreement with Evopoint Biosciences for XNW27011, a clinical-stage antibody-drug conjugate targeting CLDN18.2 for the treatment of solid tumours.
Global Pharma | 31/05/2025 | By Manvi | 186
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy